Psykey, Inc. (OTCMKTS:CEOS) Short Interest Down 88.3% in June

Psykey, Inc. (OTCMKTS:CEOS) was the target of a significant drop in short interest during the month of June. As of June 30th, there was short interest totalling 2,400 shares, a drop of 88.3% from the June 15th total of 20,600 shares. Based on an average trading volume of 546,500 shares, the short-interest ratio is currently 0.0 days.

Psykey Price Performance

Shares of CEOS remained flat at $0.03 during trading on Thursday. 1,451,733 shares of the company’s stock were exchanged, compared to its average volume of 499,435. Psykey has a 1-year low of $0.01 and a 1-year high of $0.05. The business’s fifty day moving average is $0.02 and its 200-day moving average is $0.03.

Psykey Company Profile

Psykey, Inc engages in the research, development, and commercialization of entheogenic, adaptogenic, and nootropic ingredients and formulations for its functional product lines to improve and optimize life. The company also engages in the development of technologies for the composition, bioavailability, and targeted delivery of entheogen-based therapeutics for the psychedelic market.